Nexalin Technology NXL
NASDAQ NXL
$5.73 -1.82 (-24.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Invested Capital (2021 - 2023)

Updated

Nexalin Technology (NXL) recorded Invested Capital of $3.74 million in Q3 2023, down 45.5% from $6.85 million a year earlier and down 16.8% from the prior quarter.

Analysis

Nexalin Technology (NXL) Invested Capital (2021 - 2023) Analysis & Trends

For FY2022, Nexalin Technology reported Invested Capital of $5.98 million.

  • Across earlier years, Invested Capital came in at -$1.12 million in FY2021.
  • The Q3 2023 figure is the lowest quarterly Invested Capital since Q4 2021.
  • Per Business Quant, the preceding three quarters came in at $4.49 million (Q2 2023), $5.24 million (Q1 2023) and $5.98 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 95.24 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 84.37 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 79.15 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn -
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 79.00 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 38.93 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 37.80 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 11.32 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 41.22 Bn
10 Nexalin Technology 4.20 Mn -7.59 Mn 8,897.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 3.74 Mn
Jun 30, 2023 4.49 Mn
Mar 31, 2023 5.24 Mn
Dec 31, 2022 5.98 Mn
Sep 30, 2022 6.85 Mn
Dec 31, 2021 -1.12 Mn
API Access

Nexalin Technology Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=NXL&period=max&api_key=YOUR_API_KEY